Latest TheraSphere Stories
BONN, Germany, September 29, 2014 /PRNewswire/ -- Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal
Clinical Trials Will Continue to Play a Key Role in this Growing Market, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
In the news release, The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres, issued 08-Jul-2014
Australia Has the Strongest Presence of These Innovative Products, But Competitors Are Increasingly Focusing on China, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.